Mehra MR - Search Results

1

Generic drug immunosuppression in thoracic transplantation: an ISHLT educational advisory.

Uber PA, Ross HJ, Zuckermann AO, Sweet SC, Corris PA, McNeil K, Mehra MR. Uber PA, et al. Among authors: mehra mr. J Heart Lung Transplant. 2009 Jul;28(7):655-60. doi: 10.1016/j.healun.2009.05.001. Epub 2009 Jun 3. J Heart Lung Transplant. 2009. PMID: 19560691 Review. No abstract available.

2

Current and future challenges in therapy for antibody-mediated rejection.

Nair N, Ball T, Uber PA, Mehra MR. Nair N, et al. Among authors: mehra mr. J Heart Lung Transplant. 2011 Jun;30(6):612-7. doi: 10.1016/j.healun.2011.02.002. Epub 2011 Apr 7. J Heart Lung Transplant. 2011. PMID: 21474341 Review.

3

Report from a consensus conference on the sensitized patient awaiting heart transplantation.

Kobashigawa J, Mehra M, West L, Kerman R, George J, Rose M, Zeevi A, Reinsmoen N, Patel J, Reed EF; Consensus Conference Participants. Kobashigawa J, et al. J Heart Lung Transplant. 2009 Mar;28(3):213-25. doi: 10.1016/j.healun.2008.12.017. J Heart Lung Transplant. 2009. PMID: 19285611 Free PMC article. No abstract available.

4

Bedside b-type natriuretic peptide and acute non-cellular cardiac allograft rejection.

Park MH, Scott RL, Uber PA, Mehra MR. Park MH, et al. Among authors: mehra mr. J Heart Lung Transplant. 2002 May;21(5):613-4. doi: 10.1016/s1053-2498(01)00424-7. J Heart Lung Transplant. 2002. PMID: 11983556 No abstract available.

5

Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression.

Mehra MR, Uber PA, Scott RL, Park MH. Mehra MR, et al. Transplantation. 2002 Dec 15;74(11):1568-73. doi: 10.1097/00007890-200212150-00014. Transplantation. 2002. PMID: 12490790 Clinical Trial.

6

Clopidogrel and rhabdomyolysis after heart transplantation.

Uber PA, Mehra MR, Park MH, Scott RL. Uber PA, et al. Among authors: mehra mr. J Heart Lung Transplant. 2003 Jan;22(1):107-8. doi: 10.1016/s1053-2498(02)00479-5. J Heart Lung Transplant. 2003. PMID: 12531422 No abstract available.

7

Is all intimal proliferation created equal in cardiac allograft vasculopathy? The quantity-quality paradox.

Mehra MR, Ventura HO, Uber PA, Scott RL, Park MH. Mehra MR, et al. J Heart Lung Transplant. 2003 Feb;22(2):118-23. doi: 10.1016/s1053-2498(02)00492-8. J Heart Lung Transplant. 2003. PMID: 12581758

8

TOR inhibitors and cardiac allograft vasculopathy: is inhibition of intimal thickening an adequate surrogate of benefit?

Mehra MR, Uber PA. Mehra MR, et al. J Heart Lung Transplant. 2003 May;22(5):501-4. doi: 10.1016/s1053-2498(02)00525-9. J Heart Lung Transplant. 2003. PMID: 12742410 Review. No abstract available.

9

Relationship among epicardial coronary disease, tissue myocardial perfusion, and survival in heart transplantation.

Potluri SP, Mehra MR, Uber PA, Park MH, Scott RL, Ventura HO. Potluri SP, et al. Among authors: mehra mr. J Heart Lung Transplant. 2005 Aug;24(8):1019-25. doi: 10.1016/j.healun.2004.07.017. J Heart Lung Transplant. 2005. PMID: 16102436

10

Induction therapy in heart transplantation: is there a role?

Uber PA, Mehra MR. Uber PA, et al. Among authors: mehra mr. J Heart Lung Transplant. 2007 Mar;26(3):205-9. doi: 10.1016/j.healun.2007.01.002. J Heart Lung Transplant. 2007. PMID: 17346621 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

568 results

Search Page

Filters